These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine. Saidi S; Naficy K Am J Dis Child; 1969 Aug; 118(2):209-12. PubMed ID: 5794816 [No Abstract] [Full Text] [Related]
3. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. Smorodintsev AA; Nasibov MN; Jakovleva NV Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140 [TBL] [Abstract][Full Text] [Related]
6. Immunization of children with attenuated measles-rubella bivalent vaccine. Ramos-Alvarez M; Miller BH; Jackson JE; Schwarz AJ; Bessudo L Am J Dis Child; 1975 Apr; 129(4):474-7. PubMed ID: 1093389 [TBL] [Abstract][Full Text] [Related]
7. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps]. Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598 [TBL] [Abstract][Full Text] [Related]
8. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
9. Present status of measles and rubella immunization in the United States: a medical progress report. Krugman S J Pediatr; 1971 Jan; 78(1):1-16. PubMed ID: 5539083 [No Abstract] [Full Text] [Related]
10. Revaccination against measles and rubella. Cutts FT BMJ; 1996 Mar; 312(7031):589-90. PubMed ID: 8595319 [No Abstract] [Full Text] [Related]
11. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children. Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and serological studies on live attenuated rubella virus vaccines used alone and in conjugation with measles vaccines]. Tsuji A Kansenshogaku Zasshi; 1970 Mar; 43(12):394-408. PubMed ID: 4987126 [No Abstract] [Full Text] [Related]
15. Combined vaccine against measles, mumps, rubella, and varicella. Brunell PA; Novelli VM; Lipton SV; Pollock B Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743 [TBL] [Abstract][Full Text] [Related]
16. Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines. Beasley RP; Detels R; Kim KS; Gale JL; Lin TL; Grayston JT Am J Dis Child; 1969 Aug; 118(2):301-6. PubMed ID: 4893832 [No Abstract] [Full Text] [Related]
17. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151 [TBL] [Abstract][Full Text] [Related]
19. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
20. [Indications for possibilities of preventive vaccination against measles and rubella]. Siegert R Internist (Berl); 1971 Aug; 12(8):309-12. PubMed ID: 4936452 [No Abstract] [Full Text] [Related] [Next] [New Search]